Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
Stern
R S
RS
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous